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S U M M A R Y
Introduction: The incidence, change in antibiotic susceptibility, and risk factors associated with mortality
of late-onset Klebsiella pneumoniae sepsis during 2006–2011, in a neonatal intensive care unit (NICU) of a
developing country, were analyzed.
Methods: The medical records of neonates with a discharge diagnosis of sepsis due to late-onset K.
pneumoniae were retrieved. Demographic features, gestational age, date and year of admission,
antibiotic susceptibility of isolates, and discharge status were recorded. The late-onset K. pneumoniae
incidence per 1000 NICU admissions and risk factors for mortality due to late-onset K. pneumoniae sepsis
are reported.
Results: During the period 2006–2011, 104 of 2768 neonates developed late-onset K. pneumoniae sepsis.
The overall incidence of late-onset K. pneumoniae sepsis was 3.7% (37/1000 NICU admissions), with the
highest annual incidence being 53/1000 in 2010. Most cases were males (n = 64; 62%) and most were
premature and very low birth weight (n = 68; 65%). More than 80% of isolates were resistant to ampicillin
+ clavulanic acid, gentamicin, aztreonam, and cephalosporins. An increasing trend of resistance to
amikacin, ﬂuoroquinolones, piperacillin/tazobactam, and imipenem was observed. In 2011, three-
quarters (72%; n = 13) of late-onset K. pneumoniae were CR K. pneumoniae. Seventeen (16%) neonates
died. Being male (p = 0.06, adjusted odds ratio (AOR) 9.2, 95% conﬁdence interval (CI) 1.3–66.9), having
an extremely low birth weight (p = 0.01, AOR 6.1, 95% CI 0.8–44.4), having severe thrombocytopenia (p =
0.07, AOR 3.9, 95% CI 1.2–13.0), and failure to achieve microbiological clearance (p < 0.001, AOR 19.6, 95%
CI 4.0–98.0) were signiﬁcantly associated with mortality due to late-onset K. pneumoniae sepsis.
Conclusion: There has been a rise in carbapenem-resistant strains of late-onset K. pneumoniae, associated
with an increased mortality and limited antibacterial choices. Antimicrobial stewardship and rigorous
infection control measures seem to be the only way to limit the spread of these strains.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Gram-negative organisms are the major pathogens of neonatal
sepsis in developing countries.1 Prematurity, low birth weight, and
prolonged hospitalization are the predisposing factors for neonatal
sepsis.2,3 Klebsiella pneumoniae is an important pathogen of
community-acquired and nosocomial neonatal infections,1 with
case fatality varying from 18% to 68%.4,5 Drug-resistant K.
pneumoniae has surfaced as an important pathogen in recent
years and has serious implications because of the limited antibiotic
choices, increased hospital expenditure, and poor neonatal* Corresponding author. Tel.: +92 21 34930051x4955; fax: +92 21 34934294 5.
E-mail addresses: ali.saleem@aku.edu, alfasaleem@gmail.com (A.F. Saleem).
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http://dx.doi.org/10.1016/j.ijid.2013.04.007outcome.2 A high rate (47%) of cephalosporin resistance has
previously been reported from our institute.4–6 Carbapenems (i.e.,
imipenem and meropenem) were among the ﬁrst-line agents used
against multidrug-resistant Gram-negative pathogens prior to the
emergence of carbapenem-resistant K. pneumoniae (CR K. pneu-
moniae) globally. Carbapenem resistance is conferred through the
expression of carbapenemases, encoded by mobile genes facilitat-
ing rapid horizontal spread. The emergence of these strains has
further limited the antibiotic options.7,8 Carbapenemases are
classiﬁed as class A (KPC carbapenemases), class B (metallo-beta-
lactamases), or class D (OXA-type carbapenemases).9 CR K.
pneumoniae is associated with high morbidity and mortality in
neonates, the critically ill and immunocompromised, and in
children exposed to invasive procedures.10,11 Polymyxin and
ﬂuoroquinolones are the only available options against theseses. Published by Elsevier Ltd. All rights reserved.
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antimicrobial susceptibility pattern of late-onset neonatal K.
pneumoniae from developing countries and Pakistan are limited.
We report the incidence, change in antibiotic susceptibility, and
risk factors associated with mortality of late-onset K. pneumoniae
neonatal sepsis during 2006–2011 in the neonatal intensive care
unit (NICU) of a tertiary care hospital in Pakistan.
2. Materials and methods
We retrospectively reviewed the charts of all neonates with a
discharge diagnosis of K. pneumoniae sepsis from the NICU of the
Aga Khan University Hospital (AKUH), Karachi from January 2006
to December 2011. Medical records were retrieved using the
hospital information system and International Classiﬁcation of
Diseases (ICD) codes (ICD9 CM 482.0, 041.3, and 320.82; K.
pneumoniae pneumonia, Klebsiella infection, Gram-negative men-
ingitis, respectively) and the internal birth registry of the NICU,
which holds the records of all birth and discharge diagnoses. Only
those with late-onset K. pneumoniae isolated from the blood
stream (with or without meningitis) were selected and analyzed.
AKUH is a tertiary care hospital with a 12-bed, level III NICU
(equipped with 10 conventional ventilators, two continuous
positive airway pressure (CPAP) drivers, and a high-frequency
oscillatory ventilator) providing all neonatal services except
extracorporeal membrane oxygenation (ECMO) and hemodialysis.
The NICU admits approximately 460 neonates annually. Extremely
low birth weight neonates comprise 18% of the total admissions.
There are four levels of care in our NICU: level 1 has ﬁve beds for
neonates born within the institution; level 2 has ﬁve beds for
neonates admitted via the emergency room or referred from other
hospitals; levels 3 and 4 are isolation rooms.
Admissions to the NICU come from two sources: (1) those born
in the hospital, and (2) those admitted through the emergency
room or transferred from other hospitals. The empiric antibiotic
policy of the unit recommends ampicillin and gentamicin for those
born in the hospital, while cefotaxime plus amikacin is used for
referrals, based on local epidemiological data suggesting a high
prevalence of resistant Gram-negative organisms in public sector
hospitals.13 Clinical and Laboratory Standards Institute (CLSI)
guidelines for the identiﬁcation of K. pneumoniae are followed at
the AKUH laboratory.14 The strains of K. pneumoniae were referred
to as extended-spectrum beta-lactamase (ESBL) if they were
resistant to cephalosporin, monobactams, and penicillin,15,16 and
as CR K. pneumoniae if they were resistant to carbapenems (e.g.,
meropenem and imipenem).9 A blood stream infection (BSI)
occurring after 72 h of life was termed as ‘late-onset’ and usually
related to infection acquired at home or from the hospital
environment, as mentioned.1,17 Microbiological clearance wasFigure 1. Annual incidence of late-onset Klebsiella pneumoniae per 1000 NICU adeﬁned as two or more consecutive negative blood cultures, with
no subsequent positive cultures.18
2.1. Statistical analysis
The data were analyzed using SPSS version 20 (IBM SPSS, IBM
Corp., Armonk, NY, USA). Demographic features including age (in
days) at time of admission, weight (kg), gender, year of admission,
gestational age, day of admission at the time of positive K.
pneumoniae, laboratory parameters (i.e., complete blood count and
C-reactive protein), antibiotic susceptibility of late-onset K.
pneumoniae isolates, time to microbiological clearance, and
discharge status (dead or alive at discharge) were recorded.
Means and standard deviations are reported for continuous
variables (i.e., gestational age, weight, and duration of total
parenteral nutrition (TPN)) and frequencies and percentages are
reported for categorical variables (i.e., extremely low birth weight
(weight less 1000 g), gender, and antibiotic susceptibility
pattern). The annual late-onset K. pneumoniae incidence in the
NICU is presented per 1000 NICU admissions, and antibiotic
susceptibilities are reported. Logistic regression was applied to
determine the independent risk factors for mortality. A p-value of
<0.25 was considered signiﬁcant at the univariate level. All
variables found signiﬁcant at the univariate level were entered into
a multivariable model and adjusted odds ratios (AOR) and 95%
conﬁdence intervals (CI) are reported.
2.2. Ethical approval
The study was approved by the ethics review committee (1951-
Ped-ERC-11) of the Aga Khan University, Karachi, Pakistan.
3. Results
A total of 104 out of 2768 NICU admissions were identiﬁed with
late-onset K. pneumoniae sepsis during the period 2006–2011. The
incidence was 3.7% (37/1000 NICU admissions; standard error 2.3);
the annual incidence is shown in Figure 1. The highest incidence of
late-onset K. pneumoniae was in the year 2010: 53/1000 NICU
admissions. Most of the neonates developed late-onset K.
pneumoniae during the months of May–August (n = 41; 41%).
Most were males (62%; n = 64); two-thirds (n = 69; 66%) had a
central line and three-quarters (n = 75; 72%) were ventilated. Sixty-
eight (65%) neonates were premature (mean gestational age 30.8
 3 weeks). The mean age at the time of NICU admission was 4.9  4
days (for referred newborns). Seventeen neonates (16%) died; 9 were
born in the hospital (53%).
Overall more than 80% of late-onset K. pneumoniae isolates were
resistant to ampicillin–sulbactam, gentamicin, aztreonam, anddmissions (KP, Klebsiella pneumoniae; NICU, neonatal intensive care unit).
Figure 2. Overall antibiotic resistance pattern of late-onset Klebsiella pneumoniae isolates in the NICU cohort. *Ceph: antibiotic susceptibility was checked with ceftriaxone,
cefuroxime, and ceﬁxime. Abbreviations: Amp+Clav, ampicillin + clavulanic acid; Gent, gentamicin; Aztr, aztreonam; Ceph, cephalosporin; Pip+Taz, piperacillin + tazobactam.
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susceptible to ﬂuoroquinolones and carbapenems, however only
half of the late-onset K. pneumoniae strains were susceptible to
amikacin. A trend of increasing resistance to all antibiotics was
seen (Figure 3). CR K. pneumoniae isolates were ﬁrst isolated in
2008. In 2011, three-quarters (72%; n = 13) of late-onset K.
pneumoniae were CR K. pneumoniae. Late-onset K. pneumoniae
remained susceptible to ﬂuoroquinolones. Two of the 17 neonates
who died had a CR K. pneumoniae, leading to CR K. pneumoniae case
fatality rate of 12%.
Table 1 compares the discharge status of neonates with late-
onset K. pneumoniae sepsis and the risk factors for mortality.
Having an extremely low birth weight (p = 0.01, AOR 6.1, 95% CI
0.8–44.4), being a male (p = 0.06, AOR 9.2, 95% CI 1.3–66.9), having
severe thrombocytopenia (p = 0.07, AOR 3.9, 95% CI 1.2–13.0), and
failure to achieve microbiological clearance (mean 4  2 days) (p <
0.001, AOR 19.6, 95% CI 4.0–98.0) were signiﬁcantly associated with
mortality. The choice of antibiotic management had no signiﬁcant
association with the outcome. Most children had received mechanical
ventilation, had a central line, and had received TPN for their
management; however these variables were not signiﬁcant in the
ﬁnal model. Eleven neonates (65%) did not achieve microbiological
clearance after 96 h and died.Figure 3. Annual antibiotic resistance pattern for late-onset Klebsiella pneumoniae isolate
oﬂoxacin; Imip, imipenem.4. Discussion
K. pneumoniae is a recognized cause of neonatal septicemia
worldwide.1 Our late-onset K. pneumoniae neonatal sepsis rate was
high (37/1000 NICU admissions), with increasing drug resistance
over the years. In 2010, there was high rate of nosocomial
infections in the NICU and the infection control team performed
surveillance cultures. No speciﬁc source was identiﬁed; however K.
pneumoniae was identiﬁed from a number of environment surfaces
and therefore the NICU was closed for terminal disinfection. At the
same time, hand washing certiﬁcation of the NICU staff was
performed, along with education on strict barrier nursing and
reinforcement of gown and glove precautions for suspected or
culture-proven septic neonates. Routine surveillance of hand
hygiene in the NICU indicated an increase in hand washing
compliance from 60% to 100% after these measures. The nurse to
patient ratio in our NICU remained unchanged (12 neonates/4–5
nurses). The current recommendations for the prevention of CR K.
pneumoniae outbreaks include contact precautions for infected or
colonized patients and active surveillance in high-risk units.
Seasonal variations in infections by some pathogenic Gram-
negative organisms have been observed. The incidence is
highest in the summer months and the proposed hypothesiss from the neonatal cohort. Abbreviations: Pip/Taz, piperacillin + tazobactam; Oﬂox,
Table 1





p-Value OR (95% CI) AORa (95% CI)
Neonatal features
Ageb (days) (mean  SD) 3.5  5 2.2  3 0.78 0.9 (0.7–1.3)
Gestational age (weeks) (mean  SD) 31  3 29  3 0.02 0.7 (0.6–0.9) 0.8 (0.6–1.1)
Premature (%)c 57 (66%) 11 (65%) 0.94 0.9 (0.3–2.9)
Weight (kg) (mean  SD) 2  0.9 1.8  0.9 0.30 0.7 (0.4–1.3)
ELBW 7 (8%) 5 (29%) 0.01 4.7 (1.3–17.5) 6.1 (0.8–44.4)
Male (%) 50 (57%) 14 (82%) 0.06 3.0 (0.9–9.5) 9.2 (1.3–66.9)
Ventilated (%) 53 (61%) 16 (94%) 0.01 10.2 (1.3–80.9)
Central line (%) 61 (70%) 14 (82%) 0.40 2.0 (0.5–7.5)
Hospitalization day at K. pneumoniae sepsisd (mean  SD) 9.4  9 10  13 0.80 1.0 (0.9–1.0)
TPN received (%) 71 (82%) 17 (100%) 0.07 1.2 (1.1–1.4)
TPN duration (days) (mean  SD) 12  11 15  15 0.90 1.0 (0.9–1.0)
Laboratory investigationse
WBC (109/l) 14  9 10  5 0.05 0.9 (0.8–0.9)
Neutrophils (%) 61  19 62  25 0.90 1.1 (0.9–1.3)
Platelets (109/l) 164  200 70  63 0.03 1.0 (0.9–1.0)
Severe thrombocytopeniaf 22 (25%) 8 (47%) 0.07 2.6 (0.9–7.6) 3.9 (1.2–13.0)
C-reactive protein 7.0  6 9.3  6.7 0.22 1.0 (0.9–1.2) 1.2 (1.0–1.4)
Late-onset K. pneumoniae antimicrobial susceptibility
Amikacin 45 (52%) 5 (29%) 0.09 2.6 (0.8–8.0) 1.2 (0.2–6.0)
Piperacillin + tazobactam 50 (57%) 11 (61%) 0.60 0.7 (0.3–2.2)
Fluoroquinolones 70 (80%) 14 (82%) 1.0 0.9 (0.2–3.4)
Carbapenem 69 (79%) 15 (88%) 0.52 0.5 (0.1–2.4)
Length of hospital stay (days) (mean  SD) 26  18 25  19 0.83 0.9 (0.9–1.0)
Microbiological clearance achieved (%) 79 (91%) 6 (35%) <0.001 18.1 (5.3–62.1) 19.6 (4.0–98.0)
AOR, adjusted odds ratio; CI, conﬁdence interval; ELBW, extremely low birth weight; NICU, neonatal intensive care unit; OR, odds ratio; SD, standard deviation; TPN, total
parenteral nutrition; WBC, white blood cells.
a AOR: univariate p-value <0.25 taken into account for multivariate analysis.
b Age at the time of NICU admission.
c Premature: gestational age <37 weeks.
d Day of hospital admission when the positive late-onset K. pneumoniae culture was sent.
e Laboratory investigations when the neonate become symptomatic and bacterial culture was positive for late-onset K. pneumoniae.
f Platelet count <50  109/l.
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onset K. pneumoniae rates were high during the summer
months, a ﬁnding consistent with those of previously published
studies.19,20 The majority of neonates in our study were male.
The same has been reported previously.3,21 This could be due to
a gender bias in health-seeking practices in this part of the
world.22 Moreover, the ESBL phenotype of K. pneumoniae has
been reported more frequently in males.6 Immaturity of the
immune system in premature neonates predisposes them to
nosocomial infections.1,12 Most of the neonates in our study
were premature, however this had no signiﬁcant association
with mortality (Table 1).
An increase in ESBL-producing K. pneumoniae sepsis has been
reported worldwide,1,23 and the NICU contributes most cases.24
These ESBL-producing K. pneumoniae are usually sensitive to
carbapenems.6,25 Our late-onset K. pneumoniae isolates showed a
multidrug resistance pattern with a rise in carbapenem resistance
(Figure 3). There are few therapeutic options available against CR K.
pneumoniae: imipenem or meropenem (if the minimum inhibitory
concentration (MIC) is 1 mg/ml), polymyxin, tigecycline, or a
combination of antibiotics associated with the removal of invasive
devices.26 Polymyxin B is one of the few antibiotics that can be
used for the treatment of CR K. pneumoniae and other multidrug-
resistant Gram-negative pathogens.2,12,27 CR K. pneumoniae is
associated with a high mortality.28 Eleven neonates did not achieve
microbiological clearance and died while on treatment, however
only two of them had CR K. pneumoniae. CR K. pneumoniae is
associated with an increased mortality worldwide;26,28 our CR K.
pneumoniae case fatality rate was 20%.
This was a single-center study and therefore results should be
generalized with caution. Because of the retrospective design we
were limited by the completeness of documentation; some
information was missing. Our late-onset K. pneumoniae rate couldbe high as we had an outbreak in 2010, and during outbreaks the
spread is clonal; however there were cases during the whole study
duration. This is the ﬁrst study from Pakistan reporting the clinical
characteristics and outcomes in neonates with resistant K.
pneumoniae infections.
In conclusion, our study showed an increasing incidence and
antibiotic resistance of late-onset K. pneumoniae isolates in the
NICU over the 6-year study period. KPC is a severe threat to the
healthcare system and calls for stringent standard infection control
practices in healthcare settings, with antibiotic stewardship to
control the injudicious use of antibiotics for neonatal sepsis.
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